Changes in turnover of cerebral monoamines following inhibition of enkephalin metabolism by thiorphan and bestatin
- 17 September 1984
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 104 (3-4) , 369-374
- https://doi.org/10.1016/0014-2999(84)90415-1
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Involvement of endogenous enkephalins in the mouse ‘behavioral despair’ testEuropean Journal of Pharmacology, 1984
- The analgesic effects of morphine, but not those of the enkephalinase inhibitor thiorphan, are enhanced in arthritic ratsBrain Research, 1983
- Participation of both ‘enkephalinase’ and aminopeptidase activities in the metabolism of endogenous enkephalinsNeuroscience, 1983
- Inhibition of enkepha,in metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitorEuropean Journal of Pharmacology, 1983
- In vivo potentiation of [D-ALA2]met-enkephalin amide central effects after administration of an enkephalinase inhibitorEuropean Journal of Pharmacology, 1981
- Inhibition of enkephalin-degrading aminopeptidase activity by certain peptidesBiochemical and Biophysical Research Communications, 1980
- Morphine and β-endorphin inhibit release of noradrenaline from cerebral cortex but not of dopamine from rat striatumNature, 1978
- Iontophoretic application of opiates to the locus coeruleusBrain Research, 1977
- Noradrenergic neurons: Morphine inhibition of spontaneous activityEuropean Journal of Pharmacology, 1974
- Rapid method for the determination of 5‐hydroxytryptamine and 5‐hydroxyindoleacetic acid in small regions of rat brainBritish Journal of Pharmacology, 1970